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TubulinAbstract Pharmacophore modeling, molecular docking, and in silico ADME studies have been car-
ried out to determine the binding mode and drug likeliness profile of acyl 1,3,4-thiadiazole amides and
sulfonamides as antitubulin agents. A four point pharmacophore model (AAHR.11) was generated
using 63 compounds with IC50 values ranging from 3.16 to 505.76 lM. A statistically significant
3D-QSAR model was generated from the pharmacophore hypothesis. The model had a high correla-
tion coefficient (R2 = 0.8925), cross validation coefficient (Q2 = 0.8204) and F value (44.3) at 6 com-
ponent PLS factor. The results of external validation indicated that the generated QSAR model
possessed a high predictive power (R2 = 0.83). The generated model also passed Tropsha’s test for pre-
dictive ability and Y-Randomisation test. The Domain of Applicability (APD) of the model was also
successfully defined to ascertain that a given estimation can be considered reliable. Further, the restric-
tivity of the model was checked with inactive compounds by enrichment studies using the decoy test. In
order to evaluate the effectiveness of the docking protocol, co-crystallized ligand was extracted from
the ligand binding domain of the protein and was re-docked into the same position. The conformer
obtained on re-docking and the co-crystallized ligand were superimposed and the RMSD betweention; A,
viation.
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sulfonamides as antitubulin agents. Arabianthe two was found to be 0.853 A˚. ADME predictions were also performed for these compounds. Out-
comes of the present study have been first utilized to get insight into the molecular feature that pro-
motes bioactivity, and then within screening procedure, have been exploited for the estimation of
novel potential antitubulin compounds prior to their synthesis and biological tests.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cancer continues to be the cause of a quarter of deaths in developed
countries. At present, in United States, it is the second leading reason
for deaths and in near future, it is expected to surpass heart diseases
and become the most leading cause of deaths (Shobeiri et al., 2016).
With the urgent need for development of novel and effective anticancer
agents, numerous targets are being explored by scientists.
Microtubules, formed by polymerization of tubulin heterodimers
are the key constituents of the cytoskeleton of eukaryotic cells. They
play a vital role in diverse cellular functions such as mitosis, exocytosis
and maintenance of cellular morphology, active transport, cell shape
and polarization (Kamal et al., 2016; Zghaib et al., 2016). Thereby,
tubulin is considered as an imperative target for anticancer drug dis-
covery. Various antimitotic agents that interfere with normal dynamics
of tubulin polymerization and depolymerization include taxanes, vin-
blastine and colchicines (Abbas et al., 2016; An et al., 2016).
Microtubules comprise of a/b tubulin heterodimers, which are in a
state of equilibrium (Kamal et al., 2014; Jordan et al., 1998). Micro-
tubule targeting agents, interfering with microtubule dynamic stability,
are widely employed for treatment of variety of cancers (Mollinedo
and Gajate, 2003; Zhou and Giannakakou, 2005). These agents are
also known to arrest cell division during interphase.
a and b tubulin share identical structures. Density maps for both
the subunits are almost superimposable with some differences limited
to the length and conformation of some loops, very slight displace-
ments (1 A˚) of some of the secondary structure elements, and differ-
ences in side-chain densities. Core of each monomer is comprised of
two b-sheets which are surrounded by a helices. The structure of each
monomer can be divided into three functional domains: (i) the amino-
terminal domain containing the nucleotide-binding region, (ii) an inter-
mediate domain containing the Taxol-binding site and (iii) the
carboxy-terminal domain, which probably is the part of binding sur-
face for motor proteins. However, the main binding site of drugs is
the b-subunit, residues C356 and C241 and the region 1–36. Colchicine
binds close to the interface of ab dimer (Nogales et al., 1998; Uppuluri
et al., 1993; Shearwin and Timasheff, 1994).
A number of antitubilin agents such as Vinblastine, Vincristine,
Vinorelbine, Vinflunine, Colchicine, Combretastatin, Paclitaxel, Doc-
etaxel and Epothilone find clinical application in the treatment of
numerous cancers (Mahindroo et al., 2006; Negi et al., 2015;
Dumontet, 2011). However, resistance to these agents and associated
side effects limit the use of these agents (Dumontet and Sikic, 1999;
Dumontet and Jordan, 2010). Presently, based on ligand and structure
based approaches, computational studies are considered effective tools
in medicinal chemistry, useful to accelerate the drug design process
(Cichero et al., 2014, 2016, 2011a,b; Cichero and Fossa, 2012). Previ-
ously also researchers have reported computational work on anti-
tubulin agents (Marzago and Chilin, 2014; Liao et al., 2010; Li
et al., 2015; Lokwani et al., 2013; Kandakatla et al., 2014). With these
facts, we herein report pharmacophore modeling, 3D-QSAR, molecu-
lar docking and ADME prediction of cinnamic acyl 1,3,4-thiadiazole
amides and sulfonamides to provide an insight into the key structural
features required for designing potential tubulin polymerization inhibi-
tors. The model developed in this study is a quite reliable one for all
predictions as it has been validated using different techniques. On
the basis of the developed model, various novel active compounds tar-
geting tubulin have been identified via virtual screening.. et al., Pharmacophore modeling, 3D-Q
Journal of Chemistry (2016), http://dx.2. Materials and methods
2.1. Data set
A set comprising of 63 compounds bearing cinnamic acyl
1,3,4-thiadiazole amides and sulfonamides was taken from
the available literatures (Yang et al., 2012; Luo et al., 2011)
and was used in the present study. The selected compounds
for the data set shared the same assay procedure (Hamel,
2003; Hamel and Lin, 1984) with significant variations in their
structures and potency profiles. Inhibitory potencies of the
compounds included in data set, had IC50 values varying from
3.16 to 505.76 lM which were converted into molar values.
These were then converted into pIC50 values using the formula
given below.
pIC50 ¼ log10 ½IC50
The 3D structures of ligands were generated using the
builder panel in Maestro and subsequently optimized using
LigPrep module (v3.1, Schro¨dinger 2016-1). Partial atomic
charges were ascribed and possible ionization states were gen-
erated at a pH of 7.0. The OPLS_2005 force field was used for
optimization for production of low energy conformer of the
ligand (Shivakumar et al., 2010). The energy minimization
was performed for each ligand till it reached a root mean
square deviation (RMSD) cutoff of 0.01 A˚. The resulting
structures were then taken for performing modeling studies.
2.2. Pharmacophore 3D-QSAR modeling
Phase (v4.6, Schro¨dinger 2016-1) was used for generation of
pharmacophore and 3D-QSAR models for antitubulin agents
(Dixon et al., 2006). The prepared ligands were imported for
developing pharmacophore model panel of Phase with their
respective biological activity values. The ligands were assigned
as actives with a threshold of pIC50 > 5.1 and inactives with a
threshold of pIC50 < 3.45. Remaining compounds were con-
sidered as moderately active. Phase (v4.0) has been proven to
be an important tool for flexible ligand superposition (Sastry
et al., 2011; Miller et al., 1999). In the current study, we used
phase (v4.0) shape screening for flexible alignment of the
selected antitubulin compounds. The most active compound
25 was taken as the template and pharmacophore type volume
scoring was kept as default. The default settings were used with
a maximum of 10 conformations per rotatable bonds and with
this a maximum of 100 conformers were generated. Conforma-
tions of these compounds were varied and at most one align-
ment for every ligand was retained. For assigning training
and test set for 63 compounds, random selection was made
using the Automated Random Selection option present in
Phase (v4.0) software. Test set comprised of 18 compounds
and remaining 45 compounds were included in training set.SAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and
doi.org/10.1016/j.arabjc.2016.11.004
Table 1 Intersite distances between the pharmacophoric sites
of AAHR.11.
Entry Site 1 Site 2 Distance
AAHR.11 A1 A5 5.074
AAHR.11 A1 H8 12.571
AAHR.11 A1 R11 9.703
AAHR.11 A5 H8 8.957
AAHR.11 A5 R11 5.754
AAHR.11 H8 R11 3.216
Acyl 1,3,4-thiadiazole amides and sulfonamides as antitubulin agents 3Pharmacophore sites for these compounds included default set
of chemical features of Phase: two hydrogen bond acceptors
(A), aromatic ring (R) and a hydrophobe (H). Pharmacophore
matching tolerance was set as 1 A˚. A total of 6 variants were
generated by keeping 5 and 4 as the maximum and minimum
number of sites respectively. It was specified that at least 5
of the actives must match. Finally, it resulted in 10 possible
combinations of features which could give rise to common
pharmacophores. The resulting hypotheses were scored and
ranked in accordance with their vector, volume, site scores,
survival scores and survival actives (Dixon et al., 2006) shown
in Table 3.
In the generated hypotheses, four sites were found to be
common for all selected compounds. 3D-QSAR model was
generated using Partial Least Square (PLS) regression statistics
and keeping the grid spacing of 1 A˚. The number of PLS fac-
tors included in model development is 6 because an incremen-
tal increase in the statistical significance and predictivity was
observed till 6 PLS factor (Table 4).
The distance and angles between different sites of the model
AAHR.11 are shown in Fig. 1a and 1b. This is also presented
in Tables 1 and 2. Alignment of actives and inactives with theFigure 1 Intersite (a) distances and (b) angles between the pharmacop
spheres with arrow, hydrogen bond acceptor (A); orange open circle,
Please cite this article in press as: Khan, M.F. et al., Pharmacophore modeling, 3D-Q
sulfonamides as antitubulin agents. Arabian Journal of Chemistry (2016), http://dx.generated common pharmacophore is shown in Fig. 2a and b.
Using the model, AAHR.11, fitness score of all the ligands was
evaluated (Table 5). Contour plot analysis was also done to
identify the distinct imperative pharmacophoric requirements
at spatial sites of structure.
2.3. Model validation
The QSAR model AAHR.11 with 6 component PLS factor
was characterized as the best model. Pharmacophoric modelhoric points of model AAHR.11. All distances are in A˚ unit. Pink
aromatic ring (R); green sphere, hydrophobe.
SAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and
doi.org/10.1016/j.arabjc.2016.11.004
Table 2 Intersite angles between the pharmacophoric sites of
AAHR.11.
Entry Site 1 Site 2 Site 3 Angle
AAHR.11 A5 A1 H8 35.7
AAHR.11 A5 A1 R11 28.2
AAHR.11 H8 A1 R11 7.5
AAHR.11 A1 A5 H8 124.9
AAHR.11 A1 A5 R11 127.2
AAHR.11 H8 A5 R11 2.3
AAHR.11 A1 H8 A5 19.3
AAHR.11 A1 H8 R11 23.4
AAHR.11 A5 H8 R11 4.0
AAHR.11 A1 R11 A5 24.6
AAHR.11 A1 R11 H8 149.1
AAHR.11 A5 R11 H8 173.7
4 M.F. Khan et al.was validated by its accuracy in estimation of the activity of
training set ligands. Scatter plots for experimental and pre-
dicted activities of ligands elicited significant linear correlation
and moderate difference between the experimental and pre-
dicted values shown in Fig. 3a and b. The efficacy of model
AAHR.11 was also examined with external validation. Biolog-
ical test used for compounds of both the ‘‘internal” training
and test sets was the same as used for compounds of the ‘‘ex-
ternal test set”. In order to clearly distinguish between the test
set and external test set, it is mandatory to mention that com-
pounds of training and test share structural similarity while
compounds of external test set are from a different publica-
tion. This external validation was done to check further relia-
bility of the model (Table 1: Supplementary Material and
Fig. 4). Graphs of actual value vs. predicted value and residual
value vs. predicted value were plotted.Table 3 Score of different parameters of the hypotheses.
S. no. Hypothesis Survival score Survival inactive
1. AAHR.11 3.640 1.921
2. AAHR.7 3.621 1.865
3. AAHR.9 3.597 1.805
4. AAHR.8 3.581 2.513
5. AAHR.10 3.544 1.956
6. AAHR.12 3.520 2.365
A: Acceptor; H: Hydrophobic; R: Aromatic ring.
Table 4 PLS statistical parameters of the model AAHR.11.
PLS SD R2 F P
1 0.4436 0.4627 31.9 1.899e006
2 0.3599 0.6560 34.3 4.557e009
3 0.2916 0.7805 41.5 1.286e011
4 0.2669 0.8213 39.1 2.904e012
5 0.2437 0.8555 39.1 6.229e013
6 0.2134 0.8925 44.3 3.959e014
SD: Standard deviation of regression, R2: Regression coefficient; F: Rat
ratio); P: Significance level of variance ratio; Q2: Cross validated correla
predictions.
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sulfonamides as antitubulin agents. Arabian Journal of Chemistry (2016), http://dx.The predictive power of the produced 3D-QSAR model
was also assessed by using Enalos Model Acceptability Criteria
KNIME node (Melagraki and Afantitis, 2013), which includes
all proposed tests by Tropsha (Zhang et al., 2006). Criteria fol-
lowed in developing activity/property predictors, especially for
continuous QSAR, are as follows: (i) correlation coefficient R
between the predicted and observed activities; (ii) coefficients
of determination (predicted versus observed activities R20 and
observed versus predicted activities R00
2 for regressions through
the origin); and (iii) slopes k and k0 of regression lines through
the origin. The criteria for the acceptability of the QSAR
model are represented in left column of Fig. 5.
Further validation of the model was done by enrichment
studies using the decoy test. 1000 decoy test set compounds
(Kirchmair et al., 2008) retrieved from the Schro¨dinger data
base were taken to evaluate predictive power of the model.
Enrichment factor (EF) and Robust initial enhancement
(RIE) were calculated to ensure the reliability of the model
and for the accurate ranking of compounds (Sheridan et al.,
2001).
2.4. Domain of applicability
In order to screen a QSAR model for new compounds, its
domain of application (APD) (Tropsha et al., 2003; Shen
et al., 2004) must be defined and predictions for only those
compounds that fall into this domain may be considered reli-
able. Extent of Extrapolation (Tropsha et al., 2003) is one of
the simple approaches based on the calculation of the leverage
(hi) for each chemical, where the QSPR model is used to pre-
dict its activity.
hi ¼ xi XTX
 1
xTiSite Vector Matches Activity Inactive
0.87 0.966 5 5.500 1.719
0.86 0.967 5 5.137 1.755
0.85 0.967 5 5.107 1.792
0.82 0.954 5 5.500 1.068
0.79 0.793 5 5.137 1.588
0.78 0.956 5 5.107 1.156
Stability RMSE Q2 Pearson-R
0.9890 0.3794 0.3287 0.6088
0.6025 0.311 0.5489 0.814
0.7927 0.2854 0.6202 0.857
0.7914 0.2489 0.7111 0.8866
0.7491 0.2057 0.8026 0.9168
0.7355 0.1962 0.8204 0.9124
io of the model variance to the observed activity variance (variance
tion coefficient for the test set; RMSE: the RMS error in the test set
SAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and
doi.org/10.1016/j.arabjc.2016.11.004
Figure 2 (a) Mapping of the active compounds onto the pharmacophore. (b) Mapping of inactive compounds onto the pharmacophore.
Acyl 1,3,4-thiadiazole amides and sulfonamides as antitubulin agents 5In the above equation, xi is the row vector containing the k
model parameters of the query compound and X is the n  k
matrix containing the k model parameters for each one of
the n training compounds. A leverage value greater than
3k/n is considered large. It means that the predicted response
is the result of a substantial extrapolation of the model and
may not be reliable.Please cite this article in press as: Khan, M.F. et al., Pharmacophore modeling, 3D-Q
sulfonamides as antitubulin agents. Arabian Journal of Chemistry (2016), http://dx.2.5. Y-Randomization test
Y-Randomization technique ensures the robustness of a QSPR
model (Tropsha et al., 2003; Shen et al., 2004). The dependent
variable vector is randomly shuffled and a new QSPR model is
generated. The procedure is repeated several times and the new
QSPR models are expected to have low R2 and Q2 values. InSAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and
doi.org/10.1016/j.arabjc.2016.11.004
Table 5 Calculated pIC50 for compounds in predicted set.
Ligand Chemical structure Experimental activity (pIC50) Predicted activity (pIC50) Residual activity Fitness
1t
NN
SN
H
O
4.75 4.89 0.14 2.37
2
NN
SN
H
O
F
4.74 4.81 0.07 2.66
3
N
N
S
HN
O
FF
F
4.83 4.77 0.06 2.73
4t
NN
SN
H
O
4.85 4.88 0.03 2.73
5t
N N
S N-
O
O
5.02 4.50 0.52 1.86
6
N N
S N
H
O
Cl 4.71 4.78 0.07 2.40
7
N N
S N
H
O
Cl
F
4.70 4.75 0.05 2.69
8
N N
S N
H
O
Cl
F F
F 4.71 4.66 0.05 2.75
9
N N
S N
H
O
Cl 4.87 4.83 0.04 2.76
10
N N
S N
H
O
Cl
O
4.81 5.02 0.21 2.95
11t
N N
S N
H
O
Br 4.73 4.80 0.07 2.40
12
N N
S N
H
O
Br
F
4.66 4.71 0.05 2.69
13
N N
S N
H
O
Br
F F
F 4.63 4.66 0.03 2.75
14t
N N
S N
H
O
Br 4.90 4.79 0.11 2.74
15
N N
S N
H
O
Br
O
5.00 5.04 0.04 2.95
16
N N
S N
H
O
4.82 4.88 0.06 2.40
17t
N N
S N
H
O
F
4.82 4.86 0.04 2.69
18t
N N
S N
H
O
F F
F
4.87 4.76 0.11 2.75
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Table 5 (continued)
Ligand Chemical structure Experimental activity (pIC50) Predicted activity (pIC50) Residual activity Fitness
19
N N
S N
H
O
4.90 4.92 0.02 2.74
20
N N
S N
H
O
O
5.12 5.11 0.01 2.95
21
N N
S N
H
O
O 5.04 5.12 0.08 2.45
22
N N
S N
H
O
O
F
5.06 5.08 0.02 2.72
23
N
N
S
HN
O
O
FF
F
5.10 5.04 0.06 2.76
24
N N
S N
H
O
O 5.13 5.15 0.02 2.77
25
N N
S N
H
O
O
O
5.50 5.15 0.35 3.00
26
O
N-
S
O
O
3.90 3.86 0.04 1.64
27t
O
N-
S
O
O
F
4.83 4.79 0.04 1.64
28
O
N-
S
O
O
Cl
4.82 4.54 0.28 1.64
29
O
N-
S
O
O
Br
3.73 4.36 0.63 1.64
30
F
ON-
OO S
4.83 4.78 0.05 1.86
31
F
O N-
O OS
3.90 4.19 0.29 1.84
(continued on next page)
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Table 5 (continued)
Ligand Chemical structure Experimental activity (pIC50) Predicted activity (pIC50) Residual activity Fitness
32
F
O
N-
S
O
O
F
5.12 5.11 0.01 1.84
33
F
O
N-
S
O
O
Cl
4.87 4.81 0.06 1.85
34t
F
O
N-
S
O
O
Br
4.41 4.59 0.18 1.85
35
Cl
ON-
SO O
4.32 4.30 0.02 1.92
36
Cl
O N-
S OO
4.04 3.73 0.31 1.91
37
Cl
O N-
O OS
F
4.58 4.65 0.07 1.91
38t
Cl
O
N-
S
O
O
Cl
4.58 4.33 0.25 1.91
39t
Cl
O
N-
S
O
O
Br
4.56 4.19 0.37 1.91
40
Br
ON-
OO S
3.69 3.92 0.23 1.94
41
Br
O N-
S OO
3.44 3.45 0.01 1.93
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Table 5 (continued)
Ligand Chemical structure Experimental activity (pIC50) Predicted activity (pIC50) Residual activity Fitness
42
Br
O N-
S OO
F
5.00 4.44 0.56 1.92
43
Br
O N-
S OO
Cl
3.56 4.12 0.56 1.93
44t
Br
O
N-
S
O
O
Br
3.92 3.98 0.06 1.93
45
ON-
O OS
O
3.29 3.66 0.37 1.89
46
O
N-
S
O
O
O
3.35 3.25 0.10 1.87
47t
O
N-
S
O
O
O
F
3.87 4.04 0.17 1.87
48t
O
N-
S
O
O
O
Cl
3.82 3.79 0.03 1.88
49
O
N-
S
O
O
O
Br
3.87 3.68 0.19 1.88
50
ON-
S OO
N
4.10 4.21 0.11 1.88
51
O
N-
S
O
O
N
3.96 3.73 0.23 1.86
52
O
N-
S
O
O
N
F
4.50 4.56 0.06 1.86
(continued on next page)
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Table 5 (continued)
Ligand Chemical structure Experimental activity (pIC50) Predicted activity (pIC50) Residual activity Fitness
53t
O
N-
S
O
O
N
Cl
4.08 3.98 0.10 1.87
54t
O-N
S OO
N+
-O O
3.82 3.70 0.12 1.82
55
O-
N
S
O
O
N+-O
O
3.35 3.52 0.17 1.67
56
O-
N
S
O
O
N+-O
O
F
4.74 4.56 0.18 1.65
57
O-
N
S
O
O
N+-O
O
Cl
3.43 3.49 0.06 2.12
58
O-
N
S
O
O
N+-O
O
Br
3.40 3.39 0.01 0.72
59
-O N
SO O
N+-O
O
3.65 3.83 0.18 1.94
60
O-
N
S
O
O
N+
O-O
3.53 4.02 0.49 1.04
61t
O-
N
S
O
O
N+
O-O
F
3.70 3.34 0.36 1.57
62
O-
N
S
O
O
N+
O-O
Cl
3.67 3.53 0.14 1.87
63t
O-
N
S
O
O
N+
O-O
Br
3.48 3.57 0.09 0.72
t: test.
10 M.F. Khan et al.case of opposite results, an acceptable QSPR model cannot be
obtained.
2.6. Virtual screening
PubChem database serves as an important source of com-
pounds which could be prioritized for screening for a widePlease cite this article in press as: Khan, M.F. et al., Pharmacophore modeling, 3D-Q
sulfonamides as antitubulin agents. Arabian Journal of Chemistry (2016), http://dx.range of targets. We decided to use PubChem database within
our in silico framework for virtual screening compounds which
could act as tubulin inhibitors. For this purpose, we developed
a KNIME workflow to assess the compounds that will be pri-
oritized for virtual screening. Our first aim was to mine all
compounds having structural similarity with our set of com-
pounds within PubChem database. To achieve that, we haveSAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and
doi.org/10.1016/j.arabjc.2016.11.004
Figure 3 (a): Scatter plot of the observed versus phase-predicted activity for (a) training set and (b) test set compounds with best fit line
y= 0.84x+ 0.66 (R2 = 0.83).
Acyl 1,3,4-thiadiazole amides and sulfonamides as antitubulin agents 11used Substructure Matcher node included in Indigo chemin-
formatics toolkit. All these compounds were compared to the
most active compound of our original data set in terms of sim-
ilarity given by Indigo Fingerprints. It is known that similarity
searching refers to the calculation of the similarity coefficients
for a given molecule and each compound included within a
database. Among the different proposed methodologies, simi-
larity searching using fingerprints is one of the most widely
applied methods for ligand-based screening. Fingerprints are
representations of the structural features of a molecule given
as a series of binary digits (bits) that account for the presence
or absence of particular substructures in the molecule. For this
study, Fingerprint Similarity node using Tanimoto metric for
similarity computation was used to afford the most similar
compounds that could be prioritized for screening.
All the retrieved compounds were virtually screened with
the ultimate goal of prioritizing the most promising new syn-
thetic targets. The proposed 3D-QSAR model was used to
identify the most active compounds that are proposed for fur-
ther investigation. For this, find matches option of Phase mod-
ule was used.
2.7. Molecular docking
The catalytic domain of tubulin enzyme in complex with col-
chicine (PDB Code: 1SA0) was obtained from protein data
bank and prepared using the protein preparation wizard
(Sastry et al., 2013) available in Schro¨dinger suite 2016-1.
Crystallographic water molecules i.e. without 3H bonds were
deleted and hydrogen bonds corresponding to pH 7 were
added considering the appropriate ionization states for both
acidic and basic amino acid residues. OPLS_2005 force field
was used for energy minimization of the crystal structure
(Shivakumar et al., 2010). Active site was defined with a radius
of 14 A˚ around the ligand present in crystal structure. GridPlease cite this article in press as: Khan, M.F. et al., Pharmacophore modeling, 3D-Q
sulfonamides as antitubulin agents. Arabian Journal of Chemistry (2016), http://dx.box was generated at a centroid of active site. For docking,
low energy conformations of all the compounds were docked
into the catalytic domain of tubulin protein (PDB Code:
1SA0) using Grid based Ligand Docking with Energetics
(Glide v7.0, Schro¨dinger 2016-1) (Friesner et al., 2006) in extra
precision mode without applying any constraint. The best
docked structure was identified using Glide score function,
Glide energy and Glide Emodel energy (Table 8: Supplemen-
tary Material). The lowest energy docked compound 25 was
selected for further studies. A map of hydrophobic and hydro-
philic fields for inhibitor 25 was also generated (Fig. 8).
2.8. Lipinski’s rule for drug likeliness and in silico ADME
prediction
We further predicted the drug-like behavior of the compounds
through the analysis of pharmacokinetic profile of the com-
pounds by using Qikprop module (v4.3, Schro¨dinger 2016-1).
The compounds prepared by LigPrep module (v3.1, Schro¨din-
ger 2016-1) were utilized for the calculation of pharmacoki-
netic parameters by QikProp v4.3. Physically significant
descriptors and pharmaceutically relevant properties of all
the test compounds such as molecular weight, log P, H-bond
donors, and H-bond acceptors were analyzed in accordance
with Lipinski’s rule of five (Lipinski et al., 2001).
3. Results and discussion
3.1. Pharmacophore and 3D-QSAR models
Phase (v4.0) (Dixon et al., 2006) module of Schro¨dinger 2016-1
was used for the development of pharmacophore model. Atom
based 3D-QSAR revealed the effect of substituents on activity.
Based on the sites, a maximum of four features were allowedSAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and
doi.org/10.1016/j.arabjc.2016.11.004
Figure 4 (a) Plot of actual value vs. predicted value of external training set y= 0.84x+ 0.66 (R2 = 0.83). (b) Plot of residual value vs
predicted value.
Figure 5 Screenshot of results obtained by (a) Enalos Model
Acceptability Criteria KNIME node; (b) Enalos Domain-Lever-
age node.
12 M.F. Khan et al.for developing the hypotheses. For this, 6 common hypotheses
were generated in all for 63 compounds (Table 3). The best fit-
ted model AAHR.11 (R2 = 0.8925, Q2 = 0.8204 and
F= 44.3) consists of two hydrogen bond acceptor, one
hydrophobic and aromatic ring features (Fig. 1a and b) with
highest survival score (3.640). This is also apparent from the
comparison made by the deduction of survival inactive from
survival active. It deducts inactive features from the hypothesis
and was decisively highest for the hypothesis AAHR.11.
Among the pharmacophore features, intersite distances and
angles between site points were found to be the principal attri-
bute and the point of difference between active and inactive is
due to the interstitial site distances as evident by the pharma-
cophore hypothesis AAHR.11 alignment over active
(pIC50 > 5.1) and inactive compounds (pIC50 < 3.45) in
Fig. 2a and b respectively.Please cite this article in press as: Khan, M.F. et al., Pharmacophore modeling, 3D-Q
sulfonamides as antitubulin agents. Arabian Journal of Chemistry (2016), http://dx.3.2. Model validation
The predictability and validity of the common pharmacophore
model, AAHR.11 (test set), based on active compounds were
judged by cross validation coefficient (Q2 = 0.8204) (Table 4).
Regression coefficient (R2) of the training set was 0.89, which
exhibited relevance of the model. Stability of the generated
model ranges from 0.7355 to 0.9890 on the maximum scale
of 1. The F value was found to be 44.3. Additionally, P value
of 3.959e-014 and Pearson r of 0.9124 indicated greater degree
of confidence on the model. Standard deviation (SD) value of
0.2134 and root mean square error (RMSE) of 0.1962 indicate
the stability of the generated model for estimation of unknown
compounds in the test. In order to evaluate the efficacy of the
generated model, it was further validated using an external test
set (Li et al., 2014). The calculated pIC50 values of the com-
pounds included in predicted set are given in Table 5. Predicted
values for external test set are given in Table 1 (Supplementary
Material). A plot of experimental vs. predicted pIC50 of exter-
nal test set is shown in Fig. 4a and a plot of residual vs. pre-
dicted value is shown in Fig. 4b. These two plots are vital
for the predictive ability of QSAR. Scatter residual plots were
used to identify the outliers from the QSAR model (Golbraikh
and Tropsha, 2002a,b). Fig. 4b elicits that there is no outlier in
the study. The presence or absence of outliers can be easily
determined from the scatter plot by comparing the number
of compounds taken in the test set and number of dots present
in the plot. In this case, both the numbers were same, thereby
rendering the model stable and reliable. It was able to support
the experimental pIC50 values for compounds in the external
test set. Predictive correlation coefficient R2 value of 0.83
was observed for the external test set for the developed QSAR
model. R2 value of more than 0.5 between the predicted and
experimental values renders the model to be good and was able
to predict the inhibitory activity of compounds not included in
the model development process (Golbraikh and Tropsha,
2002a,b).SAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and
doi.org/10.1016/j.arabjc.2016.11.004
Figure 6 QSAR model visualized in the context of favorable and unfavorable hydrogen bond donor effects in (a) compound 25 (5.50)
and (b) compound 45 (3.29). QSAR model visualized in the context of favorable and unfavorable hydrophobic interactions in (c)
compound 25 (5.50) and (d) compound 45 (3.29). QSAR model visualized in the context of favorable and unfavorable electron
withdrawing groups in (e) compound 25 (5.50) and (f) compound 45 (3.29).
Acyl 1,3,4-thiadiazole amides and sulfonamides as antitubulin agents 13Furthermore, the Enalos Model Acceptability Criteria
KNIME node has also been applied to the data. The model
passed Tropsha’s recommended tests for predictive ability
and the results are depicted in Fig. 5a. These results suggest
that this alignment can effectively take into consideration the
ligand-receptor interactions, and the QSAR model is thus reli-
able and could be used in the design of new tubulin inhibitors
within this structural motif of molecules.
In order to validate the discriminatory ability, the model
was screened against 1000 decoy molecules retrieved fromPlease cite this article in press as: Khan, M.F. et al., Pharmacophore modeling, 3D-Q
sulfonamides as antitubulin agents. Arabian Journal of Chemistry (2016), http://dx.the Schro¨dinger database. The model was able to find 100%
of active compounds in the hit list. RIE was calculated for
the generated models to estimate the contribution of the active
compounds ranking in the enrichment. For AAHR.11, RIE
value of 8.24 indicated the superiority of the pharmacophore
model ranking over random distribution. AUC of the ROC
curve is also considered as a reliable factor to assess the perfor-
mance of the developed model. AAHR.11 showed a good
value of 0.95 AUC and 0.99 ROC (Fig. 1 and Tables 2–5 of
Supplementary Data).SAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and
doi.org/10.1016/j.arabjc.2016.11.004
Figure 7 (a) Binding mode of compound 25 in the catalytic pocket of 1SA0, (b) 2D-ligand interaction diagram of 25 in the catalytic
pocket of 1SA0, (c) Hydrophobic interactions of 25 in the catalytic pocket of 1SA0, (d) Overlay of docked pose (magenta) of colchicine
with its crystal structure conformation (pink).
14 M.F. Khan et al.3.3. Domain of applicability
It is important that the limitations of the model are also
described via the APD. This gives an important indication as
the user can freely and creatively design novel molecules but
will be warned for the reliability of the estimation when the
structural characteristics cannot be tolerated by the model.Please cite this article in press as: Khan, M.F. et al., Pharmacophore modeling, 3D-Q
sulfonamides as antitubulin agents. Arabian Journal of Chemistry (2016), http://dx.After model validation, the APD of our model was also
defined to ascertain that a given estimation can be considered
reliable. Enalos Domains – Leverage (Extent of Extrapolation)
node that executes the aforementioned procedure is included in
our workflow and was used to assess APD of the proposed
model. In this method, the APD limit was defined as 0.167.
This limit was defined on the basis of equation provided inSAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and
doi.org/10.1016/j.arabjc.2016.11.004
Figure 8 Map of hydrophobic and hydrophilic fields for inhibitor 25 into the catalytic protein of tubulin (1SA0).
Acyl 1,3,4-thiadiazole amides and sulfonamides as antitubulin agents 15Methods section. In the APD, all the compounds fell within
the range i.e. none of the compounds was in the group of out-
liers (Fig. 5b). All these compounds were in the domain of the
applicability, and hence can be considered reliable.
3.4. Y-Randomization test
The model was further validated by applying Y-randomization.
Ten random shuffles of the Y vector were performed and the
low R2 andQ2 values were obtained. This showed that the good
results in the original model were not due to a chance correla-
tion or structural dependency of the training set. The R2 andQ2
values were in the range of 0.05 to 0.345 and 0.00 to 0.11 respec-
tively. It should be noted that for each random permutation of
the Y vector, the complete training procedure was followed for
developing the new QSPR model, including the selection of the
most appropriate descriptors.
3.5. 3D-QSAR contour map analysis
Contour plot analysis was performed to identify the effect of
spatial arrangement of structural features such as electrostatic,
ionic, hydrophobic, H-bond donor and H-bond acceptor
regions on antitubulin activity. Their individual positive con-
tribution is shown in blue cubes and negative contribution is
indicated by red cubes. Fig. 6a–f shows the comparison of
most significant favorable and unfavorable interactions, which
arise on the application of QSAR model to the most active and
least active ligands. Results of our study were found to be inPlease cite this article in press as: Khan, M.F. et al., Pharmacophore modeling, 3D-Q
sulfonamides as antitubulin agents. Arabian Journal of Chemistry (2016), http://dx.concordance with those reported by the researchers who had
synthesized and biologically evaluated these compounds
(Yang et al., 2012; Luo et al., 2011).
The hydrogen-bond donor nature for the most active com-
pound 25 (Fig. 6a) and the least active compound 45 (Fig. 6b)
when compared showed their most favorable region with blue
color and unfavorable regions with red color. Hydrogen-bond
donor mapping revealed that favorable regions lied near the
nitrogen atoms of thiadiazole, indicating their importance
for activity as compared to the least active compound 45 bear-
ing sulfone group. Therefore, the presence of thiadiazole ring
with hydrogen donor group in the scaffold backbone is vital
for the tubulin inhibitory activity. Almost all the thiadiazole
containing compounds were found to have better activity pro-
file in comparison with the ones with sulfone moiety.
Another significant component that impacts the antitubulin
activity is the hydrophobic character. Fig. 6c and d when com-
pared for their hydrophobic nature for the most active com-
pound 25 and least active compound 45 reveals that the blue
region, an indicative of hydrophobic character, around the thia-
diazole ring is essential for a compound to be an antitubulin
agent. In Fig. 6d, the presence of red cubes at para position of
phenyl ring directly attached to the sulfone group indicates that
hydrophobic groups are unfavourable at this position. This
assumption is supported by the low activity of methyl substi-
tuted compounds when compared to their unsubstituted deriva-
tives. This is evidentwhile comparing the compounds 31with 30,
36 with 35, 41 with 40, 51 with 50, 55 with 54 and 60 with 59.
In contour plot of compound 25 (Fig. 6e), the presence of
red cubes at para position of phenyl ring attached directly toSAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and
doi.org/10.1016/j.arabjc.2016.11.004
Figure 9 Superimposition of conformations of inhibitor 25: best docking pose and pose of the AAHR.11 model (RMSD: 0.870 A˚).
16 M.F. Khan et al.the thiadiazole moiety indicates that the presence of electron
withdrawing groups is undesirable at this position. This is sup-
ported by less activity of compound 6 (pIC50 4.71) having Cl
group at para position. A comparison of the para-
substituents on the same ring depicted that an electron-
donating group (16, 21) (pIC50 4.82, 5.04) have slightly
improved antitubulin activity with the potency order
OCH3 > CH3. On the contrary, the presence of blue cubes
at para position of cinnamoyl moiety indicated the preference
of electron withdrawing groups at this position. This is
explained by the significant antitubulin activity of compounds
with para halogen substitution (30, 35, 40) (pIC50 4.83, 4.32,
3.69) in the order of F > Cl > Br. The results demonstrated
that an electron-withdrawing group may have slightly
improved antitubulin activity. From the values themselves, it
is observed that the compounds substituted with electron
donating groups (compound 45: pIC50 3.29) had relatively
lower pIC50 values in comparison with the compounds with
electron withdrawing substituents and to the unsubstituted
compound 26 (pIC50 3.90).
3.6. Virtual screening
As described in the Materials and Methods section, the pro-
duced QSAR model can be used as a useful tool for screening
existing databases or virtual libraries in an effort to prioritize
potent compounds for experimental evaluation. In this con-
text, a virtual screening of structurally similar compounds
included in PubChem database was carried out using a
KNIME workflow.
First, 53,691 compounds were retrieved from the PubChem
database. Lipinski’s rule of five was used to scrutinize these
compounds. A total of 47,615 compounds were obtained after
this. These compounds were compared to the active compound
within our original database, compound 25 using fingerprints
based on the Tanimoto similarity metric as described in
Materials and Methods section. The 2542 compounds with aPlease cite this article in press as: Khan, M.F. et al., Pharmacophore modeling, 3D-Q
sulfonamides as antitubulin agents. Arabian Journal of Chemistry (2016), http://dx.Tanimoto similarity metric of over 0.80 were selected to assess
the potency of these compounds. Our approach that is based
on the scaffold and fingerprint similarity search within Pub-
Chem database resulted in a narrower chemical space that
increases the chance of success.
The pIC50 values of the 13 most potent compounds (Vs1–
Vs13) predicted with the established pharmacophore model
are listed in Table 6 of Supplementary Material. All the virtual
screening compounds were within the domain of the applica-
bility of the model, and therefore their activity estimations
can be accepted with confidence. The predicted compounds
were searched for their activity using the PubChem database
and their biological data have been reported in Table 6 (Sup-
plementary Material).
On the whole, obtained hits can serve as new chemical start-
ing points for further structural optimization of tubulin
inhibitors.
3.7. Molecular docking
The scores of docking studies are shown in Table 7 (Supple-
mentary Material). From 63 listed total-scores, pIC50 of most
compounds were in accordance with the Glide score. Docking
study revealed that interactions were dominated by the
hydrophobicity and aromaticity due to the presence of cin-
namoyl moiety. The interactions were dominated in the region
of Tyr 202, Ala 316, Ala 250 and Val 239 amino acid residues
content due to pronouncing existence of active site in the
region (Fig. 7a and b). In general, phenyl ring directly attached
to thiadiazole ring exhibited hydrophobic interactions with
Lys 254, Leu 242, Ala 250, Leu 248, Ala 354, Val 318, Lys
352, Ile 378 and Leu 255, the key residues necessary for bind-
ing of inhibitors (Fig. 7c). This is also evident by analyzing the
generated map of hydrophobic and hydrophilic fields for inhi-
bitor 25 (Fig. 8), where phenyl ring attached to thiadiazole and
cinnamoyl moiety is buried in the hydrophobic pocket (orange
color) while the ethylenic part is located in the hydrophilicSAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and
doi.org/10.1016/j.arabjc.2016.11.004
Acyl 1,3,4-thiadiazole amides and sulfonamides as antitubulin agents 17pocket (cyan color). This is in correlation with the 3D-QSAR
result where hydrophobic R11 pharmacophoric feature (cin-
namoyl moiety) and thiadiazole ring of 25 are found to be
preferable for the activity (Fig. 7c). Our Glide XP-docking
result also revealed solvent exposure in the region of thiadia-
zole and cinnamoyl moiety plays an important role in sta-
bilization of inhibitor at the active site. The compound also
showed polar interactions with amino acid residues such as
Asn 350, Thr 314, Asn 258, Asn 349, Thr 240 and Thr 239.
Binding mode and 2D ligand interaction diagram of least
active compound of the series (45) are shown in Fig. 2 of Sup-
plementary Material. This compound showed polar interac-
tions with Thr 314, Asn 350, Asn 349, Asn 258 and Thr 353.
aa residues Met 259, Ile 378, Val 315, Leu 248, Leu 255 and
some others were responsible for formation of hydrophobic
bonds with the compound. The only positively charged residue
responsible for interactions was Lys 352. On the whole, extent
of interactions for least active compound (45) was much less in
comparison with that exhibited by the most active compound
(25).
In addition, the accuracy of the docking procedure was
determined by examining how closely the lowest energy poses
(binding conformation) predicted by the object scoring func-
tion, Glide score (GScore), which resembles an experimental
binding mode as determined by X-ray crystallography. The
root mean square deviation (RMSD) between the predicted
conformation and the observed X-ray crystallographic confor-
mation of colchicines (PDB Code: 1SA0) was found to be
0.853 A˚ (Fig. 7d), a value that suggests the reliability of Glide
XP docking mode in reproducing the experimentally observed
binding mode of tubulin polymerization inhibitors and the
parameter set for Glide XP docking is reasonable to reproduce
the X-ray structure. Further, similar orientation was observed
between the superposition of conformation 25 best XP-
docking pose and 3D-QSAR pose (RMSD: 0.870 A˚) (Fig. 9).
3.8. Lipinski’s rule for drug likeliness and in silico ADME
prediction
Different pharmacokinetic parameters of the compounds
taken for the study were subjected to ADME predictions by
Qikprop v4.3. The compounds were assessed for their basic
parameters of Lipinski’s rule of 5 and other pharmacokinetic
parameters. Table 8 (Supplementary Material) shows the
results obtained from Qikprop with their permissible range.
In general, an orally active compound should not have more
than 2 violations of the Lipinski rule. The active test com-
pounds in present study were not found violating the rule more
than the maximum permissible limits and thus proving their
drug likeness properties.
The optimum values of the descriptors, polar surface area
and rotatable bonds also have great influence on oral bioavail-
ability of the drug molecules. The important parameters with
their permissible ranges are delineated in Table 8 (Supplemen-
tary Material). The optimum value of rotatable bonds (0–15)
and polar surface area (7–200 A˚) holds a great importance
on the oral bioavailability of the drug molecules. The active
test acyl 1,3,4-thiadizole amide and sulfonamides derivatives
demonstrated results of the descriptors, which were found to
be within the prescribed range, thus owing to good bioavail-
ability. Intestinal absorption or permeation is also one of thePlease cite this article in press as: Khan, M.F. et al., Pharmacophore modeling, 3D-Q
sulfonamides as antitubulin agents. Arabian Journal of Chemistry (2016), http://dx.important factors to be studied in concern with the absorption
of the drug molecule, which was further confirmed by pre-
dicted Caco-2 cell permeability (QPPCaco), used as model
for gut-blood barrier. Caco-2 cell permeability prediction of
the test compounds indicates excellent results, predicting good
intestinal absorption. Further, the test results for QPlogkhsa
descriptor of Qikprop indicating the predicted values of
human serum albumin binding indicated that test molecules
were found to fall within the permissible range (1.5 to 1.5).
Also, the Qikprop descriptor for blood/brain partition coeffi-
cient QPlogBB showed reliable prediction for all the test com-
pounds and reference drugs. The cell permeability of the blood
brain barrier that mimics MDCK cells (QPPMDCK) also dis-
played reliable results as they were well within the prescribed
range. The aqueous solubility parameter (QPlog S) of the test
entities was assessed and the compounds were also found to be
in the permissible range (<0.5).
4. Conclusion
Combined computational approach was applied to give insight into the
structural basis and inhibition mechanism for a series of acyl 1,3,4-
thiadizole amide and sulfonamides as antitubulin agents. 3D-QSAR
modeling was performed to provide a structural framework for under-
standing the structure activity relationship of these compounds. The
atom based 3D-QSAR generated model AAHR.11 exhibited good cor-
relation and predictive power and satisfactory agreement between
experiment and theory. Molecular docking studies were performed
to produce possible binding poses for these compounds to tubulin.
The low value of RMSD between the initial complex structure and
the energy minimized final average complex structure suggests that
the derived docked complex is close to the equilibrium. Further,
ADME predictions were performed for these compounds. Conclu-
sively, the hits obtained on virtual screening of the database have pro-
vided new chemical starting points for design and development of
novel tubulin targeting agents.
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